Works in Cancer Chemotherapy & Pharmacology, 2010, Vol 66, Issue 6

Results: 22

Carboplatin with weekly docetaxel and ifosfamide in advanced head and neck cancers: a phase I Brown University Oncology Group dose escalation study (HN-93)

Published in:

2010

By:

Rathore R;
Birnbaum A;
Rathore B;
Dipetrillo T;
Kennedy T;
Ready N

Publication type:

Journal Article

Zonula Occludens-1 alterations and enhanced intestinal permeability in methotrexate-treated rats.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1031, doi. 10.1007/s00280-010-1253-9

By:

Hamada, Kazuma;
Shitara, Yoshihisa;
Sekine, Shuichi;
Horie, Toshiharu

Publication type:

Article

Phase I trial of non-cytotoxic suramin as a modulator of docetaxel and gemcitabine therapy in previously treated patients with non-small cell lung cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1019, doi. 10.1007/s00280-010-1252-x

By:

Lam, Elaine T.;
Au, Jessie L.-S.;
Otterson, Gregory A.;
Wientjes, M. Guillaume;
Ling Chen;
Shen, Tong;
Yong Wei;
Xiaobai Li;
Bekii-Saab, Tanios;
Murgo, Anthony J.;
Jensen, Rhonda R.;
Grever, Michael;
Villalona-Calero, Miguel A.

Publication type:

Article

Carboplatin with weekly docetaxel and ifosfamide in advanced head and neck cancers: a phase I Brown University Oncology Group dose escalation study (HN-93).

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1013, doi. 10.1007/s00280-010-1251-y

By:

Rathore, Ritesh;
Birnbaum, Ariel;
Rathore, Bharti;
DiPetrillo, Thomas;
Kennedy, Teresa;
Ready, Neal

Publication type:

Article

Inhibition of established subcutaneous murine tumour growth with topical Melaleuca alternifolia (tea tree) oil.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1095, doi. 10.1007/s00280-010-1267-3

By:

Greay, Sara J.;
Ireland, Demelza J.;
Kissick, Haydn T.;
Heenan, Peter J.;
Carson, Christine F.;
Riley, Thomas V.;
Beilharz, Manfred W.

Publication type:

Article

Resistance to platinum-based chemotherapy in lung cancer cell lines.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1103, doi. 10.1007/s00280-010-1268-2

By:

Jianli Chen;
Emara, Nashwa;
Solomides, Charalambos;
Parekh, Hemant;
Simpkins, Henry

Publication type:

Article

Hepatotoxicity of intra-arterial combination chemotherapy in patients with liver cirrhosis and advanced hepatocellular carcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1123, doi. 10.1007/s00280-010-1270-8

By:

Nagai, Hidenari;
Matsui, Teppei;
Kanayama, Masahiro;
Momiyama, Kouichi;
Shizawa, Kazue;
Wakui, Noritaka;
Shinohara, Mie;
Watanabe, Manabu;
Iida, Kazunari;
Ishii, Koji;
Igarashi, Yoshinori;
Sumino, Yasukiyo

Publication type:

Article

Phase I clinical trial of hepatic arterial infusion of cisplatin in combination with intravenous liposomal doxorubicin in patients with advanced cancer and dominant liver involvement.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1087, doi. 10.1007/s00280-010-1266-4

By:

Tsimberidou, Apostolia M.;
Moulder, Stacy;
Siqing Fu;
Sijin Wen;
Aung Naing;
Bedikian, Agop Y.;
Daring, Shawn;
Uehara, Cynthia;
Chaan Ng;
Wallace, Michael;
Camacho, Luis;
Kurzrock, Razelle

Publication type:

Article

Sonodynamically induced apoptosis and active oxygen generation by gallium-porphyrin complex, ATX-70.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1071, doi. 10.1007/s00280-010-1264-6

By:

Yumita, Nagahiko;
Okudaira, Kazuho;
Momose, Yasunori;
Umemura, Shin-ichiro

Publication type:

Article

The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1131, doi. 10.1007/s00280-010-1455-1

By:

Yi-kang Shi;
Zhong-hua Li;
Xi-qian Han;
Ji-hu Yi;
Zhen-hua Wang;
Jing-li Hou;
Cong-ran Feng;
Qing-hong Fang;
Hui-hui Wang;
Peng-fei Zhang;
Feng-shan Wang;
Jie Shen;
Peng Wang

Publication type:

Article

Development of a modeling framework to simulate efficacy endpoints for motesanib in patients with thyroid cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1141, doi. 10.1007/s00280-010-1449-z

By:

Claret, Laurent;
Jian-Feng Lu;
Yu-Nien Sun;
Bruno, René

Publication type:

Article

Population pharmacokinetic/pharmacodynamic modeling for the time course of tumor shrinkage by motesanib in thyroid cancer patients.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1151, doi. 10.1007/s00280-010-1456-0

By:

Jian-Feng Lu;
Claret, Laurent;
Sutjandra, Liviawati;
Kuchimanchi, Mita;
Melara, Rebeca;
Bruno, René;
Yu-Nien Sun

Publication type:

Article

Biweekly docetaxel, cisplatin, and 5-fluorouracil (DCF) chemotherapy for advanced esophageal squamous cell carcinoma: a phase I dose-escalation study.

Published in:

2010

By:

Tanaka, Yoshihiro;
Yoshida, Kazuhiro;
Sanada, Yuichi;
Osada, Shinji;
Yamaguchi, Kazuya;
Takahashi, Takao

Publication type:

Report

Optimizing ixabepilone treatment schedules in patients with advanced or metastatic breast cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1005, doi. 10.1007/s00280-010-1467-x

By:

Egerton, Nancy

Publication type:

Article

A phase II study of bevacizumab plus erlotinib for gemcitabine-refractory metastatic pancreatic cancer.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1051, doi. 10.1007/s00280-010-1257-5

By:

Ko, Andrew H.;
Venook, Alan P.;
Bergsland, Emily K.;
Kelley, R. Kate;
Korn, W. Michael;
Dito, Elizabeth;
Schillinger, Brian;
Scott, Janet;
Hwang, Jimmy;
Tempero, Margaret A.

Publication type:

Article

Bendamustine pharmacokinetic profile and exposure-response relationships in patients with indolent non-Hodgkin's lymphoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1039, doi. 10.1007/s00280-010-1254-8

By:

Owen, Joel S.;
Melhem, Murad;
Passarell, Julie A.;
D'Andrea, Denise;
Darwish, Mona;
Kahl, Bradley

Publication type:

Article

Hyper-alkalinization without hyper-hydration for the prevention of high-dose methotrexate acute nephrotoxicity in patients with osteosarcoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1059, doi. 10.1007/s00280-010-1259-3

By:

Mir, Olivier;
Ropert, Stanislas;
Babinet, Antoine;
Alexandre, Jérôme;
Larousserie, Frédérique;
Durand, Jean-Philippe;
Enkaoua, Eric;
Anract, Philippe;
Goldwasser, François

Publication type:

Article

An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1065, doi. 10.1007/s00280-010-1262-8

By:

Naito, Seiji;
Tsukamoto, Taiji;
Usami, Michiyuki;
Fujimoto, Hiroyuki;
Akaza, Hideyuki

Publication type:

Article

A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1079, doi. 10.1007/s00280-010-1265-5

By:

Paik, Paul K.;
Rudin, Charles M.;
Brown, Andrew;
Rizvi, Naiyer A.;
Takebe, Naoko;
Travis, William;
James, Leonard;
Ginsberg, Michelle S.;
Juergens, Rosalyn;
Markus, Susan;
Tyson, Leslie;
Subzwari, Sara;
Kris, Mark G.;
Krug, Lee M.

Publication type:

Article

A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1113, doi. 10.1007/s00280-010-1269-1

By:

Dickson, Mark A.;
Shah, Manish A.;
Rathkopf, Dana;
Tse, Archie;
Carvajal, Richard D.;
Nian Wu;
Lefkowitz, Robert A.;
Gonen, Mithat;
Cane, Lauren M.;
Dials, Heather J.;
Schwartz, Gary K.

Publication type:

Article

Pharmacokinetics, efficacy and toxicity of different pegylated liposomal doxorubicin formulations in preclinical models: is a conventional bioequivalence approach sufficient to ensure therapeutic equivalence of pegylated liposomal doxorubicin products?

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1173, doi. 10.1007/s00280-010-1406-x

By:

Mamidi, Rao N. V. S.;
Weng, Steve;
Stellar, Susan;
Wang, Charles;
Ning Yu;
Huang, Tony;
Tonelli, Alfred P.;
Kelley, Michael F.;
Angiuoli, Anthony;
Man-Cheong Fung

Publication type:

Article

Value of gene polymorphisms as markers of 5-FU therapy response in stage III colon carcinoma: a pilot study.

Published in:

Cancer Chemotherapy & Pharmacology, 2010, v. 66, n. 6, p. 1167, doi. 10.1007/s00280-010-1403-0

By:

Fariña-Sarasqueta, Arantza;
van Lijnschoten, Gesina;
Rutten, Harm J. T.;
van den Brule, Adriaan J. C.

Publication type:

Article